アイテム詳細

登録内容を編集

このアイテムは取り下げられました。詳細要約

取り下げ

学術論文

Human SPG11 cerebral organoids reveal cortical neurogenesis impairment

MPS-Authors

Buchsbaum, Isabel Y.
Max Planck Research Group Developmental Neurobiology (Silvia Cappello), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons189184

Cappello, Silvia
Max Planck Institute of Psychiatry, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

公開されているフルテキストはありません

付随資料 (公開)

There is no public supplementary material available

引用

Perez-Branguli, F., Buchsbaum, I. Y., Pozner, T., Regensburger, M., Fan, W., Schray, A., Boerstler, T., Mishra, H., Graef, D., Kohl, Z., Winkler, J., Berninger, B., Cappello, S., & Winner, B. (2019). Human SPG11 cerebral organoids reveal cortical neurogenesis impairment. Human Molecular Genetics, 28(6), 961-971. doi:10.1093/hmg/ddy397.

要旨

Spastic paraplegia gene 11(SPG11)-linked hereditary spastic paraplegia is a complex monogenic neurodegenerative disease that in addition to spastic paraplegia is characterized by childhood onset cognitive impairment, thin corpus callosum and enlarged ventricles. We have previously shown impaired proliferation of SPG11 neural progenitor cells (NPCs). For the delineation of potential defect in SPG11 brain development we employ 2D culture systems and 3D human brain organoids derived from SPG11 patients' iPSC and controls. We reveal that an increased rate of asymmetric divisions of NPCs leads to proliferation defect, causing premature neurogenesis. Correspondingly, SPG11 organoids appeared smaller than controls and had larger ventricles as well as thinner germinal wall. Premature neurogenesis and organoid size were rescued by GSK3 inhibititors including the Food and Drug Administration-approved tideglusib. These findings shed light on the neurodevelopmental mechanisms underlying disease pathology.